CellgramDC-WT1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CellgramDC-WT1, covering 2023-12-15 to 2023-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard Chemotherapy [Phase 1, Phase 2]